The group of SSc-PAH patients displayed the lowest Se status, i.e., significantly reduced concentrations of Se (Figure 2A), and SELENOP (Figure 2B), as well as reduced GPx3 activity (Figure 2C). Here, SELENOP is linked to systemic sclerosis.